Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study
Archives of Gynecology and Obstetrics · 01.07.2026 · 313 (1)
DOI: 10.1007/s00404-026-08500-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 01.07.2026. Verfasst von Lillian Sun Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Pregnancy Complications, Neoplastic, Treatment Delay, Delayed Diagnosis, Time-to-Treatment. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kræftens Bekæmpelse, National Hospital.
Abstract (Originalsprache)
Purpose
More advanced stages at diagnosis and lower survival rates are seen in women diagnosed with cancer during pregnancy compared to non-pregnant women with similar cancers. This study aims to investigate diagnostic and treatment delays, cancer stage, and survival in Danish pregnant cancer patients.
Methods
Patients from the Danish cancer in pregnancy database were included. Cancer diagnosis, treatment, and obstetrical data were collected from the database. Time to treatment was compared to national cancer patient pathways. Cancer stages at diagnosis were compared to epidemiological studies identified through a systematic literature search. Survival was compared to data from NORDCAN, a Nordic cancer statistics database.
Results
The study included 74 patients diagnosed with cancer in pregnancy. The median total delay was 43.5 days (IQR 27.75–94.75) with a patient delay of three days (IQR 0–31), a diagnostic delay of 15 days (IQR 8–35), and a treatment delay of 9.5 days (IQR 0–19). Time from cancer suspicion to start of treatment fell within recommended national cancer patient pathway intervals in 80.0% of cases. Breast cancer and melanoma in pregnancy tended to have more advanced stages at diagnosis compared to non-pregnant patients. The 1- and 5-year mortality rates were 5.4% and 17.6%, respectively.
Conclusion
Our findings suggest that pregnant cancer patients presented with advanced stages at diagnosis and lower survival rates compared to non-pregnant patients with similar cancers. Our results indicate that the main contributor to the delay in cancer in pregnancy in Denmark is delayed suspicion of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark.
- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark. lone.storgaard.01@regionh.dk.
Förderung
- Kræftens Bekæmpelse
- National Hospital
Zitieren
APA
Liang, L. S., Greiber, I. K., Karlsen, M. A., Pedersen, B. W., Nielsen, B. B., Have, M. K., Helmig, R. B., Schmidt, M. C., Strandbygaard, J., & Storgaard, L. (2026). Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-026-08500-5
Vancouver
Liang LS, Greiber IK, Karlsen MA, Pedersen BW, Nielsen BB, Have MK, et al. Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-026-08500-5
BibTeX
@article{Liang2026,
author = {Liang, Lillian Sun and Greiber, Iben Katinka and Karlsen, Mona Aarenstrup and Pedersen, Berit Woetmann and Nielsen, Birgitte Bruun and Have, Malene Kronborg and Helmig, Rikke Bek and Schmidt, Maria Cathrine and Strandbygaard, Jeanett and Storgaard, Lone},
title = {Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
volume = {313},
number = {1},
doi = {10.1007/s00404-026-08500-5}
}
EUVIMED